Despite the COVID-19 pandemic, the U.S. Food and Drug Administration is still working on approving drugs as best the regulatory agency can, although the FDA did recently announce the possibility of non-COVID-19 work being delayed. Here is a look at some target action dates on the schedule.

Pacira Pharmaceuticals will discontinue manufacturing of its DepoCyt product due to “persistent technical issues.” In addition to shuttering the drug production, Pacira will also terminate employees associated with manufacturing of the drug.

Chinese regulators approved Pfizer Inc.’s blockbuster vaccine Prevenar 13, a breakthrough for the firm after it was forced to shut its vaccine business in China during 2015.

A total of 202 people have been detained in connection with a scandal over an illegal black market vaccine ring, the Chinese government said on Wednesday, as it vowed to improve supervision of the market. The case, involving millions of illegal trades of vaccines through a black market drugs ring, has ignited public ire and […]

Drug distributor AmerisourceBergen Corp agreed to buy PharMEDium Healthcare Holdings Inc for $2.58 billion from private equity firm Clayton, Dubilier & Rice, expanding its business of supplying compounded drugs to hospitals. Compounding is a process in which pharma products are diluted to create doses that are not sold commercially. Increased regulatory oversight following a fungal […]

The U.S. Centers for Disease Control and Prevention on Wednesday recommended that decisions to use new meningitis B vaccines from Pfizer and GlaxoSmithKline in people aged 16 to 23 be made on an individual patient basis by physicians, the companies said, potentially paving the way for wider access to the drugs. The CDC stopped short […]

ATLANTA–(BUSINESS WIRE)–The Advisory Committee on Immunization Practices (ACIP), a sub committee of the Centers for Disease Control and Prevention (CDC) today recommended that newly available vaccinations to combat the “B” strain of meningitis only be considered for use by individuals and their physicians. The committee opted to recommend the meningitis vaccine as category B rather […]